Overbeek, Remco
ORCID: 0000-0002-4046-0234, Leitl, Christoph J.
ORCID: 0000-0002-6274-5708, Stoll, Sandra E.
ORCID: 0000-0002-4803-1362, Wetsch, Wolfgang A.
ORCID: 0000-0001-5800-6665, Kammerer, Tobias
ORCID: 0000-0001-8920-7187, Mathes, Alexander
ORCID: 0000-0002-0231-0681, Böttiger, Bernd W.
ORCID: 0000-0001-8000-8931, Seifert, Harald
ORCID: 0000-0002-7732-4762, Hart, Dominique
ORCID: 0009-0002-0360-1082 and Dusse, Fabian
ORCID: 0000-0001-7762-6966
(2024).
The Value of Next-Generation Sequencing in Diagnosis and Therapy of Critically Ill Patients with Suspected Bloodstream Infections: A Retrospective Cohort Study.
Journal of Clinical Medicine, 13 (2).
pp. 1-12.
MDPI.
ISSN 2077-0383
|
PDF
jcm-13-00306-v2.pdf Bereitstellung unter der CC-Lizenz: Creative Commons Attribution. Download (643kB) |
Abstract
[Artikel-Nr.: 306] Bloodstream infection (BSI), a frequent cause of severe sepsis, is a life-threatening complication in critically ill patients and still associated with a high mortality rate. Rapid pathogen identification from blood is crucial for an early diagnosis and the treatment of patients with suspected BSI. For this purpose, novel diagnostic tools on the base of genetic analysis have emerged for clinical application. The aim of this study was to assess the diagnostic value of additional next-generation sequencing (NGS) pathogen test for patients with suspected BSI in a surgical ICU and its potential impact on antimicrobial therapy. In this retrospective single-centre study, clinical data and results from blood culture (BC) and NGS pathogen diagnostics were analysed for ICU patients with suspected BSI. Consecutive changes in antimicrobial therapy and diagnostic procedures were evaluated. Results: 41 cases with simultaneous NGS and BC sampling were assessed. NGS showed a statistically non-significant higher positivity rate than BC (NGS: 58.5% (24/41 samples) vs. BC: 21.9% (9/41); p = 0.056). NGS detected eight different potentially relevant bacterial species, one fungus and six different viruses, whereas BC detected four different bacterial species and one fungus. NGS results affected antimicrobial treatment in 7.3% of cases. Conclusions: NGS-based diagnostics have the potential to offer a higher positivity rate than conventional culture-based methods in patients with suspected BSI. Regarding the high cost, their impact on anti-infective therapy is currently limited. Larger randomized prospective clinical multicentre studies are required to assess the clinical benefit of this novel diagnostic technology.
| Item Type: | Article |
| Creators: | Creators Email ORCID ORCID Put Code |
| URN: | urn:nbn:de:hbz:38-817014 |
| Identification Number: | 10.3390/jcm13020306 |
| Journal or Publication Title: | Journal of Clinical Medicine |
| Volume: | 13 |
| Number: | 2 |
| Page Range: | pp. 1-12 |
| Number of Pages: | 12 |
| Date: | 5 January 2024 |
| Publisher: | MDPI |
| ISSN: | 2077-0383 |
| Language: | English |
| Faculty: | Faculty of Medicine |
| Divisions: | Faculty of Medicine > Anästhesiologie und Operative Intensivmedizin > Klinik für Anästhesiologie und Operative Intensivmedizin Faculty of Medicine > Medizinische Mikrobiologie, Immunologie und Hygiene > Institut für Medizinische Mikrobiologie, Immunologie und Hygiene |
| Subjects: | Medical sciences Medicine |
| Uncontrolled Keywords: | Keywords Language next-generation sequencing ; sepsis ; antimicrobial therapy ; DISQVER ; pathogen detection ; blood culture English |
| ['eprint_fieldname_oa_funders' not defined]: | Publikationsfonds UzK |
| Refereed: | Yes |
| URI: | http://kups.ub.uni-koeln.de/id/eprint/81701 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
![]() |
View Item |
https://orcid.org/0000-0002-4046-0234